Malaysian Health Technology Assessment Section (MaHTAS)
is tasked to provide evidence-based input on health technology and clinical practice.
is tasked to provide evidence-based input on health technology and clinical practice.
Latest fromMaHTAS
Job Vacancy
We're Hiring!
Good news to our dedicated MOH medical officers! The Malaysian Health Technology Assessment Section (MAHTAS) is on the lookout for talented individuals to join our growing team. If you're keen to dive into a career in Health Technology Assessment and Clinical Practice Guidelines, this could be your next big step!
We're seeking medical officers at grade UD10-UD12 with about 5 years of experience, a strong team spirit, and a thirst for new knowledge. Post-grad qualifications and research experience are a definite plus!
Ready to contribute to shaping healthcare technologies in Malaysia? Find all the details on how to apply in the poster below.
Be sure to send your CV to This email address is being protected from spambots. You need JavaScript enabled to view it. before the deadline of 10 October 2025.
Come join us! We look forward to welcoming you aboard!
I-Nation Global Summit 2025 in Conjunction with NICE 2025
Date: 6–9 October 2025
MaHTAS officers represented the Ministry of Health at the event organised by MRANTI and MOSTI at the World Trade Centre, Kuala Lumpur. The event gathered innovators, researchers, and policymakers to explore R&D, commercialisation, and funding strategies aligned with the 13th Malaysia Plan. Discussions focused on AI, HealthTech, and Life Sciences, highlighting how collaboration and innovation can drive a more sustainable healthcare system in Malaysia.
TACHTEE Meeting 2/2025
Date: 1 October 2025
MaHTAS held its second Technical Advisory Committee on Health Technologies Economic Evaluation (TACHTEE) meeting of 2025, chaired by Dr. Maznah Dahlui. The session welcomed Dr. Syaqirah Akmal as the new Deputy Director of MaHTAS and discussed the economic evaluation of TB-LAM for high-risk TB patients. Members also reviewed key studies on Full Paying Patient services and health inequality, reaffirming MaHTAS’ commitment to evidence-based, equitable healthcare decisions.
ISPOR Asia Pacific HTA Roundtable
Date: 28 September 2025
MaHTAS participated in the ISPOR Asia Pacific HTA Roundtable alongside regional HTA leaders. Represented by Dr. Izzuna Ghazali and Dr. Roza Sarimin, Malaysia contributed to discussions on HTA’s role in pricing negotiations, efficiency, and collaboration. Delegates also joined the ISPOR RWE Summit 2025, which highlighted innovative solutions to healthcare challenges in the region.
Centre of Informed Decision Making in Malaysia
"Is it safe? Is it effective? Is it cost-effective"
MaHTAS is responsible in assessing health technologies and advocating evidence-informed decision-making for better health care.
MaHTAS is responsible in assessing health technologies and advocating evidence-informed decision-making for better health care.
MaHTAS conduct horizon scanning, health technology assessment (HTA), develop and implement Clinical Practice Guidelines (CPG).